Current low-level SARS-CoV-2 circulation documented by CDC and WHO surveillance underpins the 96.5% market-implied probability against a new coronavirus pandemic in 2026. As of early August 2026, test positivity remains near 3–4% globally, emergency department visits for COVID-19 sit at just 0.2%, and hospitalizations stay minimal, reflecting stable endemic transmission rather than exponential growth. Widespread population immunity from prior infections and updated vaccines continues to limit severe outcomes, while circulating Omicron sublineages show no antigenic shifts or sustained zoonotic jumps required to meet pandemic thresholds. Realistic scenarios that could alter the outcome before year-end include emergence of a novel coronavirus with efficient human-to-human respiratory transmission or a major immune-escape variant enabling widespread severe disease, both of which ongoing genomic monitoring would detect early.